Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 151 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Oleksiak, MF; Kolell, KJ; Crawford, DL
      Utility of natural populations for microarray analyses: Isolation of genesnecessary for functional genomic studies

      MARINE BIOTECHNOLOGY
    2. Qureshi, AA; Sami, SA; Salser, WA; Khan, FA
      Synergistic effect of tocotrienol-rich fraction (TRF25) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans

      JOURNAL OF NUTRITIONAL BIOCHEMISTRY
    3. Tsuda, M; Sanada, M; Nakagawa, H; Kodama, I; Sakashita, T; Ohama, K
      Phenotype of apolipoprotein E influences the lipid metabolic response of postmenopausal women to hormone replacement therapy

      MATURITAS
    4. Kobayashi, T; Homma, Y
      Effects of low-dose pravastatin on plasma levels of lipids and apolipoproteins in Japanese type II hyperlipoproteinemic subjects with apolipoprotein E phenotype E3/2, E3/3, and E4/3

      JOURNAL OF CLINICAL PHARMACOLOGY
    5. Illingworth, DR; Tobert, JA
      HMG-CoA reductase inhibitors

      ADVANCES IN PROTEIN CHEMISTRY, VOL 56
    6. Gidding, SS
      Cholesterol guidelines debate

      PEDIATRICS
    7. Real, JT; Chaves, FJ; Civera, M; Garcia-Garcia, AB; Ascaso, JF; Armengod, ME; Carmena, R
      Influence of FH Valencia 1 and 2 mutations of the LDL receptor gene on theresponse to simvastatin in subjects with molecularly defined heterozygous familial hypercholesterolemia in Spain

      MEDICINA CLINICA
    8. Li, SR; Koller, E; Valent, P; Gludovacz, D; Yang, Q; Patri, P; Angelberger, P; Dudczak, R; Virgolini, I
      Effects of vasoactive intestinal peptide (VIP) and somatostatin (SST) on lipoprotein receptor expression by A431 tumor cells

      LIFE SCIENCES
    9. Solis, C; Aizencang, GI; Astrin, KH; Bishop, DF; Desnick, R
      Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria

      JOURNAL OF CLINICAL INVESTIGATION
    10. Pedro-Botet, J; Schaefer, EJ; Bakker-Arkema, RG; Black, DM; Stein, EM; Corella, D; Ordovas, JM
      Apolipoprotein E genotype affects plasma lipid response to atorvastatin ina gender specific manner

      ATHEROSCLEROSIS
    11. Brorholt-Petersen, JU; Jensen, HK; Raungaard, B; Gregersen, N; Faergeman, O
      LDL-receptor gene mutations and the hypocholesterolemic response to statintherapy

      CLINICAL GENETICS
    12. Wilmink, HW; Twickler, MB; Banga, JD; Dallinga-Thie, GM; Eeltink, H; Erkelens, DW; Rabelink, TJ; Stroes, ES
      Effect of statin versus fibrate on postprandial endothelial dysfunction: role of remnant-like particles

      CARDIOVASCULAR RESEARCH
    13. Ginsberg, HN
      Hypertriglyceridemia: New insights and new approaches to pharmacologic therapy

      AMERICAN JOURNAL OF CARDIOLOGY
    14. Siest, G; Bertrand, P; Herbeth, B; Vincent-Viry, M; Schiele, F; Sass, C; Visvikis, S
      Apolipoprotein E polymorphisms and concentration in chronic diseases and drug responses

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    15. Ekstrom, U; Abrahamson, M; Sveger, T; Sun, XM; Soutar, AK; Nilsson-Ehle, P
      Expression of an LDL receptor allele with two different mutations (E256K and I402T)

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    16. Hagberg, JM; Wilund, KR; Ferrell, RE
      APO E gene and gene-environment effects on plasma lipoprotein-lipid levels

      PHYSIOLOGICAL GENOMICS
    17. Leviev, I; James, RW
      Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    18. Twickler, TB; Dallinga-Thie, GM; de Valk, HW; Schreuder, PCNJ; Jansen, H; Cabezas, MC; Erkelens, DW
      High dose of simvastatin normalizes postprandial remnant-like particle response in patients with heterozygous familial hypercholesterolemia

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    19. Saint-Jore, B; Varret, M; Dachet, C; Rabes, JP; Devillers, M; Erlich, D; Blanchard, P; Krempf, M; Mathe, D; Chanu, B; Jacotot, B; Farnier, M; Bonaiti-Pellie, C; Junien, C; Boileau, C
      Autosomal dominant type IIa hypercholesterolemia: evaluation of the respective contributions of LDLR and APOB gene defects as well as a third major group of defects

      EUROPEAN JOURNAL OF HUMAN GENETICS
    20. Salazar, LA; Hirata, MH; Quintao, ECR; Hirata, RDC
      Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene inBrazilian patients with primary hypercholesterolemia

      JOURNAL OF CLINICAL LABORATORY ANALYSIS
    21. Rawool, NM; Nazarian, LN
      Ultrasound of the ankle and foot

      SEMINARS IN ULTRASOUND CT AND MRI
    22. Ballantyne, CM; Herd, JA; Stein, EA; Ferlic, LL; Dunn, JK; Gotto, AM; Marian, AJ
      Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    23. Akosah, KO; Gower, E; Groon, L; Rooney, BL; Schaper, A
      Mild hypercholesterolemia and premature heart disease: Do the national criteria underestimate disease risk?

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    24. Cicero, AFG; Braiato, A; D'Addato, S; Sangiorgi, Z; Gaddi, A
      A suggestion for familial hypercholesterolemia (FH) heterozygosity clinical diagnosis based on epidemiological observations in a large Italian population

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    25. Sinzinger, H; Chehne, F; Schmid, P; Kritz, H
      Plasma homocysteine is not altered during simvastatin-therapy

      WIENER KLINISCHE WOCHENSCHRIFT
    26. Dobs, AS; Schrott, H; Davidson, MH; Bays, H; Stein, EA; Kush, D; Wu, M; Mitchel, Y; Illingworth, RD
      Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis inmen with hypercholesterolemia

      METABOLISM-CLINICAL AND EXPERIMENTAL
    27. Dobs, AS; Miller, S; Neri, G; Weiss, S; Tate, AC; Shapiro, DR; Musliner, TA
      Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients

      METABOLISM-CLINICAL AND EXPERIMENTAL
    28. Illingworth, R
      Management of hypercholesterolemia

      MEDICAL CLINICS OF NORTH AMERICA
    29. Heath, KE; Whittall, RA; Miller, GJ; Humphries, SE
      I705 variant in the low density lipoprotein receptor gene has no effect onplasma cholesterol levels

      JOURNAL OF MEDICAL GENETICS
    30. Parhofer, KG; Barrett, PHR; Demant, T; Schwandt, P
      Acute effects of low density lipoprotein apheresis on metabolic parametersof apolipoprotein B

      JOURNAL OF LIPID RESEARCH
    31. Frikke-Schmidt, R; Wittrup, HH; Tybjaerg-Hansen, A; Meinertz, H; Schnohr, P; Nordestgaard, BG
      Apolipoprotein E genotypes predict attendance rates at lipid clinic

      ATHEROSCLEROSIS
    32. Sniderman, AD; Zhang, XJ; Cianflone, K
      Governance of the concentration of plasma LDL: a reevaluation of the LDL receptor paradigm

      ATHEROSCLEROSIS
    33. Raungaard, B; Jensen, HK; Brorholt-Petersen, JU; Heath, F; Faergeman, O
      Functional characterization of two low density lipoprotein receptor gene mutations by fluorescence flow cytometric assessment of receptor activity instimulated human T-lymphocytes

      CLINICAL GENETICS
    34. Batalla, A; Alvarez, R; Reguero, JR; Hevia, S; Iglesias-Cubero, G; Alvarez, V; Cortina, A; Gonzalez, P; Celada, MM; Medina, A; Coto, E
      Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction

      CLINICAL CHEMISTRY
    35. Thompson, GR
      Poor responders to statins: a potential target for stanol esters

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    36. Bambauer, R; Schneidewind, JM; Latza, R
      Apheresis technologies for prevention and regression of atherosclerosis: Clinical results

      ASAIO JOURNAL
    37. Wang, CL; Shieh, JY; Wang, TG; Hsieh, FJ
      Ultrasonographic assessment of posterior heel pain

      JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
    38. Salazar, LA; Hirata, MH; Giannini, SD; Forti, N; Diament, J; Issa, JS; Hirata, RDC
      Effects of Ava II and Hinc II polymorphisms at the LDL receptor gene on serum lipid levels of Brazilian individuals with high risk for coronary heartdisease

      JOURNAL OF CLINICAL LABORATORY ANALYSIS
    39. Packard, CJ
      Session on the pathophysiology of apolipoprotein metabolism - Apolipoprotein B metabolism in dyslipidaemia and the effect of drugs

      DIABETES NUTRITION & METABOLISM
    40. Martinoli, C; Bianchi, S; Derchi, LE
      Tendon and nerve sonography

      RADIOLOGIC CLINICS OF NORTH AMERICA
    41. Fessell, DP; van Holsbeeck, MT
      Foot and ankle sonography

      RADIOLOGIC CLINICS OF NORTH AMERICA
    42. Korhonen, T; Hannuksela, ML; Seppanen, S; Kervinen, K; Kesaniemi, YA; Savolainen, MJ
      The effect of the apolipoprotein E phenotype on cholesteryl ester transferprotein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    43. Donner, MG; Parhofer, KG; Richter, WO; Schwandt, P
      Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis

      METABOLISM-CLINICAL AND EXPERIMENTAL
    44. Smit, JWA; De Bruin, TWA; Eekhoff, EMW; Glatz, J; Erkelens, DW
      Combined hyperlipidemia is associated with increased exercise-induced muscle protein release which is improved by triglyceride-lowering intervention

      METABOLISM-CLINICAL AND EXPERIMENTAL
    45. Parhofer, KG; Demant, T; Ritter, MM; Geiss, HC; Donner, M; Schwandt, P
      Lipoprotein (a) metabolism estimated by nonsteady-state kinetics

      LIPIDS
    46. Frenais, R; Ouguerram, K; Maugeais, C; Marchini, JS; Benlian, P; Bard, JM; Magot, T; Krempf, M
      Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia:a stable isotope study

      JOURNAL OF LIPID RESEARCH
    47. Nishimura, S; Sekiguchi, M; Kano, T; Ishiwata, S; Nagasaki, F; Nishide, T; Okimoto, T; Kutsumi, Y; Kuwabara, Y; Takatsu, F; Nishikawa, H; Daida, H; Yamaguchi, H
      Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS)

      ATHEROSCLEROSIS
    48. Parhofer, KG; Barrett, PHR; Schwandt, P
      Low density lipoprotein apolipoprotein B metabolism: comparison of two methods to establish kinetic parameters

      ATHEROSCLEROSIS
    49. Gaudet, D; Vohl, MC; Couture, P; Moorjani, S; Tremblay, G; Perron, P; Gagne, C; Despres, JP
      Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men

      ATHEROSCLEROSIS
    50. Ekstrom, U; Abrahamson, M; Floren, CH; Tollig, H; Wettrell, G; Nilsson, E; Sun, XM; Soutar, AK; Nilsson-Ehle, P
      An individual with a healthy phenotype in spite of a pathogenic LDL receptor mutation (C240F)

      CLINICAL GENETICS
    51. Davignon, J; Cohn, JS; Mabile, L; Bernier, L
      Apolipoprotein E and atherosclerosis: insight from animal and human studies

      CLINICA CHIMICA ACTA
    52. von Kodolitsch, Y; Pyeritz, RE; Rogan, PK
      Splice-site mutations in atherosclerosis candidate genes - Relating individual information to phenotype

      CIRCULATION
    53. Maugeais, C; Ouguerram, K; Krempf, N; Magot, T
      Kinetic study of apo B100 containing lipoprotein metabolism using amino acids labeled with stable isotopes: Methodological aspects

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    54. MOHAMMADI A; MACRI J; NEWTON R; ROMAIN T; DULAY D; ADELI K
      EFFECTS OF ATORVASTATIN ON THE INTRACELLULAR STABILITY AND SECRETION OF APOLIPOPROTEIN-B IN HEPG2 CELLS

      Arteriosclerosis, thrombosis, and vascular biology
    55. SOUTAR AK
      UPDATE ON LOW-DENSITY-LIPOPROTEIN RECEPTOR MUTATIONS

      Current opinion in lipidology
    56. Kobayashi, T; Homma, Y; Handa, S; Nakamura, H
      Influence of apolipoprotein E phenotype on changes in plasma levels of low-density lipoprotein-cholesterol and apolipoprotein B due to the effects ofsimvastatin

      NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
    57. BERNINI GP; BROGI G; ARGENIO GF; MORETTI A; SALVETTI A
      EFFECTS OF LONG-TERM PRAVASTATIN TREATMENT ON SPERMATOGENESIS AND ON ADRENAL AND TESTICULAR STEROIDOGENESIS IN MALE HYPERCHOLESTEROLEMIC PATIENTS

      Journal of endocrinological investigation
    58. THIERY J; TEUPSER D
      GENETIC-FACTORS OF ATHEROGENESIS

      Zeitschrift fur Kardiologie
    59. RINDONE JP; HILLER D; ARRIOLA G
      A COMPARISON OF FLUVASTATIN 40 MG EVERY OTHER DAY VERSUS 20 MG EVERY DAY IN PATIENTS WITH HYPERCHOLESTEROLEMIA

      Pharmacotherapy
    60. BHATNAGAR D
      LIPID-LOWERING DRUGS IN THE MANAGEMENT OF HYPERLIPIDEMIA

      Pharmacology & therapeutics (Oxford)
    61. SCHRAMA YC; HENE RJ; DEJONGE N; JOLES JA; VANRIJN HJM; BAR DR; VERVERS TFT; VANTOL A; KOOMANS HA
      EFFICACY AND MUSCLE SAFETY OF FLUVASTATIN IN CYCLOSPORINE-TREATED CARDIAC AND RENAL-TRANSPLANT RECIPIENTS - AN EXERCISE PROVOCATION TEST

      Transplantation
    62. Tvorogova, MG; Susekov, AV; Semenova, OA; Kukharchuk, VV; Titov, VN
      Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia

      TERAPEVTICHESKII ARKHIV
    63. SANLLEHY C; CASALS E; RODRIGUEZVILLAR C; ZAMBON D; OJUEL J; BALLESTA AM; ROS E
      LACK OF INTERACTION OF APOLIPOPROTEIN-E PHENOTYPE WITH THE LIPOPROTEIN RESPONSE TO LOVASTATIN OR GEMFIBROZIL IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA

      Metabolism, clinical and experimental
    64. LALA A; SCOPPOLA A; MOTTI C; CORTESE C; CACCESE D; MENZINGER G
      APOLIPOPROTEIN-E GENOTYPE AND CHOLESTEROGENESIS IN POLYGENIC HYPERCHOLESTEROLEMIA

      Metabolism, clinical and experimental
    65. CIVEIRA F; CASTILLO JJ; CALVO C; FERRANDO J; DEPEDRO C; MARTINEZRODES P; POCOVI M
      ACHILLES-TENDON SIZE BY HIGH-RESOLUTION SONOGRAPHY IN HEALTHY POPULATION - RELATIONSHIP WITH LIPID-LEVELS

      Medicina Clinica
    66. LAHOZ C; MOSTAZA JM
      THE ANATOMY OF LIPID DEPOSITS

      Medicina Clinica
    67. CARMENA R
      APOLIPOPROTEIN-E AND RESPONSE TO STATINS

      Medicina Clinica
    68. LEE WK; HADDAD L; MACLEOD MJ; DORRANCE AM; WILSON DJ; GAFFNEY D; DOMINICZAK MH; PACKARD CJD; DAY INM; HUMPHRIES SE; DOMINICZAK AF
      IDENTIFICATION OF A COMMON LOW-DENSITY-LIPOPROTEIN RECEPTOR MUTATION (C163Y) IN THE WEST OF SCOTLAND

      Journal of Medical Genetics
    69. PEETERS AV; KOTZE MJ; SCHOLTZ CL; DEWAAL LF; RUBINSZTEIN DC; COETZEE GA; ZULIANI G; STREIFF R; LIU JW; VANDERWESTHUYZEN DR
      A 3-BASEPAIR DELETION IN REPEAT-1 OF THE LDL RECEPTOR PROMOTER REDUCES TRANSCRIPTIONAL ACTIVITY IN A SOUTH-AFRICAN PEDI

      Journal of lipid research
    70. BERGER GMB; PEGORARO RJ; PATEL SB; NAIDU P; ROM L; HIDAKA H; MARAIS AD; JADHAV A; NAOUMOVA RP; THOMPSON GR
      HMG-COA REDUCTASE IS NOT THE SITE OF THE PRIMARY DEFECT IN PHYTOSTEROLEMIA

      Journal of lipid research
    71. JONES PJH; AUSMAN LM; CROLL DH; FENG JY; SCHAEFER EA; LICHTENSTEIN AH
      VALIDATION OF DEUTERIUM INCORPORATION AGAINST STEROL BALANCE FOR MEASUREMENT OF HUMAN CHOLESTEROL-BIOSYNTHESIS

      Journal of lipid research
    72. Aguilar-Salinas, CA; Barrett, H; Schonfeld, G
      Metabolic modes of action of the statins in the hyperlipoproteinemias

      ATHEROSCLEROSIS
    73. Pinto, X
      Genes, hypercholesterolaemia and carotid atherosclerosis

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    74. Drager, LJ; Julius, U; Kraenzle, K; Schaper, J; Toepfer, M; Zygan, K; Otto, V; Steinhagen-Thiessen, E
      DALI - the first human whole-blood low-density lipoprotein and lipoprotein(a) apheresis system in clinical use: procedure and clinical results

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    75. MALLOY MJ; KANE JP
      AGGRESSIVE MEDICAL THERAPY FOR THE PREVENTION AND TREATMENT OF CORONARY-ARTERY DISEASE

      Disease-a-month
    76. GAUDET D; VOHL MC; PERRON P; TREMBLAY G; GAGNE C; LESIEGE D; BERGERON J; MOORJANI S; DESPRES JP
      RELATIONSHIPS OF ABDOMINAL OBESITY AND HYPERINSULINEMIA TO ANGIOGRAPHICALLY ASSESSED CORONARY-ARTERY DISEASE IN MEN WITH KNOWN MUTATIONS INTHE LDL RECEPTOR GENE

      Circulation
    77. CAREW JA; POLLAK ES; HIGH KA; BAUER KA
      SEVERE FACTOR-VII DEFICIENCY DUE TO A MUTATION DISRUPTING AN SP1 BINDING-SITE IN THE FACTOR-VII PROMOTER

      Blood
    78. NAOUMOVA RP; KIM KD; NEUWIRTH C; NITHTHYANANTHAN S; RENDELL NB; TAYLOR GW; THOMPSON GR
      CHOLESTEROL-SYNTHESIS IS INCREASED IN MIXED HYPERLIPIDEMIA

      Biochimica et biophysica acta, L. Lipids and lipid metabolism
    79. O KM; LYNN EG; CHUNG YH; SIOW YL; MAN RYK; CHOY PC
      HOMOCYSTEINE STIMULATES THE PRODUCTION AND SECRETION OF CHOLESTEROL IN HEPATIC CELLS

      Biochimica et biophysica acta, L. Lipids and lipid metabolism
    80. GOA KL; BARRADELL LB; MCTAVISH D
      SIMVASTATIN - A REAPPRAISAL OF ITS COST-EFFECTIVENESS IN DYSLIPIDEMIAAND CORONARY HEART-DISEASE

      PharmacoEconomics
    81. CUCHEL M; SCHAEFER EJ; MILLAR JS; JONES PJH; DOLNIKOWSKI GG; VERGANI C; LICHTENSTEIN AH
      LOVASTATIN DECREASES DE-NOVO CHOLESTEROL-SYNTHESIS AND LDL APO B-100 PRODUCTION-RATES IN COMBINED-HYPERLIPIDEMIC MALES

      Arteriosclerosis, thrombosis, and vascular biology
    82. SPENCER TA; CLARK DS; JOHNSON GA; ERICKSON SK; CURTISS LK
      FEASIBILITY OF AN IMMUNOASSAY FOR MEVALONOLACTONE

      Bioorganic & medicinal chemistry
    83. HUFF MW; BURNETT JR
      3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITORS AND HEPATIC APOLIPOPROTEIN-B SECRETION

      Current opinion in lipidology
    84. OTAKE S; IMAGUMBAI N; TAJIMA A; OHBA S
      UNUSUAL HIGH SIGNAL INTENSITY ON MR-IMAGES IN A PATIENT WITH MULTIPLETENDINOUS XANTHOMAS

      European radiology
    85. SCHMIDT EB
      N-3 FATTY-ACIDS AND THE RISK OF CORONARY HEART-DISEASE

      Danish medical bulletin
    86. VARRET M; RABES JP; COLLODBEROUD G; JUNIEN C; BOILEAU C; BEROUD C
      SOFTWARE AND DATABASE FOR THE ANALYSIS OF MUTATIONS IN THE HUMAN LDL RECEPTOR GENE

      Nucleic acids research
    87. LAHOZ C; ORDOVAS JM
      APO-E - PLASMA-LIPIDS, ISCHEMIC-HEART-DIS EASE AND ALZHEIMER-DISEASE

      Medicina Clinica
    88. ILMONEN M; EBELING T; VIIKARI J; OJALA JP; TIKKANEN MJ
      SCREENING OF THE 3' 2 3 OF THE CODING AREA OF THE APO-B-GENE IN FINNISH HYPERCHOLESTEROLEMIC PATIENTS - REPORT OF 6 NEW GENETIC-VARIANTS/

      Atherosclerosis
    89. NISSEN H; HANSEN AB; GULDBERG P; PETERSEN NE; HANSEN TS; HORDER M
      DETECTION AND CHARACTERIZATION OF A NOVEL SPLICE MUTATION IN THE LDL RECEPTOR INTRON-12 RESULTING IN 2 DIFFERENT MUTANT MESSENGER-RNA VARIANTS

      Atherosclerosis
    90. NAGGERT JK; RECINOS A; LAMERDIN JE; KRAUSS RM; NISHINA PM
      THE ATHEROGENIC LIPOPROTEIN PHENOTYPE IS NOT CAUSED BY A MUTATION IN THE CODING REGION OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE

      Clinical genetics
    91. SASAKI S; NAKAGAWA M; NAKATA T; ENDO N; MIYAO K; KITAMURA K; FUKUYAMA M; KITANI T; YAMADA C
      EFFICACY AND SAFETY OF THE 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITOR FLUVASTATIN IN HYPERLIPIDEMIC PATIENTS TREATED WITH PROBUCOL

      Cardiology
    92. PIRILLO A; JACOVIELLO C; LONGONI C; RADAELLI A; CATAPANO AL
      SIMVASTATIN MODULATES THE HEAT-SHOCK RESPONSE AND CYTOTOXICITY MEDIATED BY OXIDIZED LDL IN CULTURED HUMAN ENDOTHELIAL SMOOTH-MUSCLE CELLS

      Biochemical and biophysical research communications
    93. JONES PJH
      REGULATION OF CHOLESTEROL-BIOSYNTHESIS BY DIET IN HUMANS

      The American journal of clinical nutrition
    94. JENSEN LG; JENSEN HK; HEATH F; EIBERG H; KJELDSEN M; FAERGEMAN O; KOLVRAA S; BOLUND L; GREGERSEN N
      ALLELE-SPECIFIC MEASUREMENT OF LOW-DENSITY-LIPOPROTEIN RECEPTOR TRANSCRIPT LEVELS

      Human mutation
    95. TAILLEUX A; FRUCHART JC
      HDL HETEROGENEITY AND ATHEROSCLEROSIS

      Critical reviews in clinical laboratory sciences
    96. DAVIGNON J
      A LIPID CLINIC ASSOCIATED WITH A RESEARCH LABORATORY WORKING ON DYSLIPOPROTEINEMIAS AND ATHEROSCLEROSIS

      Canadian journal of cardiology
    97. DESAGER JP; HORSMANS Y
      CLINICAL PHARMACOKINETICS OF 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE INHIBITORS

      Clinical pharmacokinetics
    98. CONTOIS JH; ANAMANI DE; TSONGALIS GJ
      THE UNDERLYING MOLECULAR MECHANISM OF APOLIPOPROTEIN-E POLYMORPHISM -RELATIONSHIPS TO LIPID DISORDERS, CARDIOVASCULAR-DISEASE, AND ALZHEIMERS-DISEASE

      Clinics in laboratory medicine
    99. BRUCKERT E; GIRAL P; HESHMATI HM; TURPIN G
      MEN TREATED WITH HYPOLIPEMIC DRUGS COMPLAIN MORE FREQUENTLY OF ERECTILE DYSFUNCTION

      Journal of clinical pharmacy and therapeutics
    100. KHOSLA P; SUNDRAM K
      EFFECTS OF DIETARY FATTY-ACID COMPOSITION ON PLASMA-CHOLESTEROL

      Progress in lipid research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 15:16:52